Wei‐Zhong Wu

机构：Fudan University, Zhongshan Hospital · ORCID：0000-0002-4936-7220

发表论文 157 篇 · 总被引 7486 次 · h-index 48

代表论文

Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges (2023 · Biomarker Research · 被引 63)
GPC3-IL7-CCL19-CAR-T primes immune microenvironment reconstitution for hepatocellular carcinoma therapy (2023 · Cell Biology and Toxicology · 被引 50)
miR-612 Enhances RSL3-Induced Ferroptosis of Hepatocellular Carcinoma Cells via Mevalonate Pathway (2023 · Journal of Hepatocellular Carcinoma · 被引 22)
LAYN Serves as a Prognostic Biomarker and Downregulates Tumor-Infiltrating CD8+ T Cell Function in Hepatocellular Carcinoma (2024 · Journal of Hepatocellular Carcinoma · 被引 12)
Epstein‐Barr virus‐driven metabolic alterations contribute to the viral lytic reactivation and tumor progression in nasopharyngeal carcinoma (2024 · Journal of Medical Virology · 被引 12)
ALOXE3 transcriptionally regulated by activating transcription factor 3 promotes HCC ferroptosis via ERK and JNK signaling pathway (2025 · International Immunopharmacology · 被引 5)